Abstract
In asthma, bronchial mucosal tissues are chronically infiltrated by activated inflammatory cells (mainly lymphocytes and eosinophils) that have the capacity to produce a wide range of cytokines (IL-4, IL-5) and mediators (leucotrienes, prostaglandins, etc.). These molecules may significantly change the functional and phenotypic behavior of resident cells (epithelial cells, fibroblasts, smooth muscle cells, etc.) In addition to their role in tissue repair, resident cells are an important source of cytokines. They play an active role in modulating the immune response, suggesting that they may be involved in the maintenance and chronicity of the inflammatory response. These cells are also involved in structural changes observed in asthma, such as subepithelial fibrosis [3]. The alteration in the structure of the bronchial tree appears to be one of the factors involved in the persistence of bronchial hyperreactivity [4]. This review will focus on the role of structural cells on airway remodeling and their response to asthma medication.
Keywords: Asthma, airway remodeling, epithelium repair, fibroblasts, asthma medication
Current Respiratory Medicine Reviews
Title: The Role of Structural Cells on Airway Remodeling and Their Response to Asthma Medication
Volume: 4 Issue: 1
Author(s): Jamila Chakir, Abdelhabib Semlali and Eric Jacques
Affiliation:
Keywords: Asthma, airway remodeling, epithelium repair, fibroblasts, asthma medication
Abstract: In asthma, bronchial mucosal tissues are chronically infiltrated by activated inflammatory cells (mainly lymphocytes and eosinophils) that have the capacity to produce a wide range of cytokines (IL-4, IL-5) and mediators (leucotrienes, prostaglandins, etc.). These molecules may significantly change the functional and phenotypic behavior of resident cells (epithelial cells, fibroblasts, smooth muscle cells, etc.) In addition to their role in tissue repair, resident cells are an important source of cytokines. They play an active role in modulating the immune response, suggesting that they may be involved in the maintenance and chronicity of the inflammatory response. These cells are also involved in structural changes observed in asthma, such as subepithelial fibrosis [3]. The alteration in the structure of the bronchial tree appears to be one of the factors involved in the persistence of bronchial hyperreactivity [4]. This review will focus on the role of structural cells on airway remodeling and their response to asthma medication.
Export Options
About this article
Cite this article as:
Chakir Jamila, Semlali Abdelhabib and Jacques Eric, The Role of Structural Cells on Airway Remodeling and Their Response to Asthma Medication, Current Respiratory Medicine Reviews 2008; 4 (1) . https://dx.doi.org/10.2174/157339808783497783
DOI https://dx.doi.org/10.2174/157339808783497783 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmaceutical Nanotechnology United States Patent Watch (January – March 2016)
Pharmaceutical Nanotechnology Immunomodulatory Properties of ES-62, a Phosphorylcholine - Containing Glycoprotein Secreted by Acanthocheilonema viteae
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Patents in Pulmonary Delivery of Macromolecules
Recent Patents on Drug Delivery & Formulation The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
Current Drug Discovery Technologies Dietary Nutrients in Relation to Chronic Obstructive Pulmonary Disease: Emerging Epidemiological Evidence
Current Respiratory Medicine Reviews Chemogenomics with Peptide Secondary Structure Mimetics
Combinatorial Chemistry & High Throughput Screening Synthesis and Antibacterial Activity of Novel Chalcone Derivatives of Apocynin
Letters in Drug Design & Discovery Role of Oxidative Stress in Polycystic Ovary Syndrome
Current Women`s Health Reviews Extraction, Structure and Bioactivities of the Polysaccharides from Fructus corni
Recent Patents on Food, Nutrition & Agriculture Subclinical Vitamin B12 Deficiency and Heart Rate Variability Across Life Cycle
Current Aging Science Animal Models of Pulmonary Emphysema
Current Drug Targets - Inflammation & Allergy Pain Perception and Management: Where do We Stand?
Current Molecular Pharmacology CCR1 Chemokine Receptor Antagonist
Current Pharmaceutical Design Pharmacogenetics and the Pharmaceutical Industry
Current Pharmaceutical Design Ligands for A2B Adenosine Receptor Subtype
Current Medicinal Chemistry Same Target, Different Therapeutic Outcomes: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma
Combinatorial Chemistry & High Throughput Screening Recent Advances in the Characterization of Genetic Factors Involved in Human Susceptibility to Infection by Schistosomiasis
Current Genomics Influence of Ultrafine Particles Exposure on Asthma Exacerbation in Children: A Meta-Analysis
Current Drug Targets Multi-target Pharmacological Effects of Platycodin D
Mini-Reviews in Organic Chemistry Targeting the Histamine H4 Receptor: Future Drugs for Inflammatory Diseases
Current Organic Chemistry